NCT05997719 Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC
| NCT ID | NCT05997719 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | Non-small Cell Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-08-10 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2023-08-10 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate genomic architecture, cancer evolution and their relationship with clinical outcomes in EGFR-mutant NSCLC.
Eligibility Criteria
Inclusion Criteria: 1. Aged 18 years or older 2. Histologically or cytologically confirmed non-small-cell lung cancer 3. ECOG PS=0-2 4. EGFR mutations confirmed by tissue or peripheral blood 5. Can provide tumor tissue samples (fresh or archived) 6. The subject should have good compliance, who would participate in the research voluntarily, and sign the informed consent Exclusion Criteria: 1. History of other malignancies within 5 years (excluding basal cell carcinoma of the skin or other carcinoma in situ that has been resected). 2. Unable to provide sufficient tumor tissue for analysis. 3. Subjects with active, unstable systemic diseases, such as active infection, uncontrolled hypertension, heart failure (NYHA class \>= II), unstable angina pectoris, acute coronary syndrome, severe arrythmia, severe liver, kidney or metabolic diseases, HIV infection. 4. Subjects who are deemed unable to comply with the study requirements or complete the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05997719 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-small Cell Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05997719 currently recruiting?
Yes, NCT05997719 is actively recruiting participants. Contact the research team at zhaoshen@sysucc.org.cn for enrollment information.
Where is the NCT05997719 trial being conducted?
This trial is being conducted at Guanzhou, China.
Who is sponsoring the NCT05997719 clinical trial?
NCT05997719 is sponsored by Sun Yat-sen University. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.